DOP014: Impact of genetic variation on gene and protein expression in Crohn’s diseaseECCO '18 Vienna
2018
DOP015: Dysregulation of cell-type-specific long ncRNA in the ileum of treatment naïve early onset Crohn diseaseECCO '18 Vienna
2018
DOP016: Metagenomic analysis of intestinal mucosa revealed an IBD-specific shift in the eukaryotic gut virome composition at early stages of gut inflammationECCO '18 Vienna
2018
DOP017: Increased intestinal aryl hydrocarbon receptor expression and pathway sensitivity in Crohn’s diseaseECCO '18 Vienna
2018
DOP018: Baseline ILC1 distribution in blood predicts response to ustekinumab in patients with refractory Crohn’s diseaseECCO '18 Vienna
2018
DOP019: Immunomodulators reduce the risk of surgery and hospitalisation in Crohn’s disease in a prospective European population-based inception cohort: the Epi-IBD cohortECCO '18 Vienna
2018
DOP020: Thiopurine monotherapy still has a place in the treatment of patients with mild-to-moderate Crohn’s disease in the biological eraECCO '18 Vienna
2018
DOP022: Tacrolimus suppositories as induction therapy for refractory ulcerative proctitis: a randomised controlled trialECCO '18 Vienna
2018
DOP023: Tofacitinib for the treatment of ulcerative colitis: up to 4.4 years of safety data from global clinical trialsECCO '18 Vienna
2018
DOP025: Tofacitinib for the treatment of ulcerative colitis: analysis of malignancy rates from the OCTAVE clinical programmeECCO '18 Vienna
2018
DOP027: Efficacy and safety of an additional 8 weeks of tofacitinib induction therapy: Results of the OCTAVE open study for tofacitinib 8-week induction non-respondersECCO '18 Vienna
2018
DOP028: Second N-ECCO Consensus Statements on the European nursing roles in caring for patients with Crohn’s disease or ulcerative colitisECCO '18 Vienna
2018
DOP029: Treatment and long-term outcomes of paediatric patients with penetrating Crohn’s diseaseECCO '18 Vienna
2018
DOP030: The efficacy of home telemonitoring vs. conventional follow-up: a randomised controlled trial among teenagers with inflammatory bowel diseaseECCO '18 Vienna
2018
DOP031: Individualised home-monitoring of disease activity in adult patients with inflammatory bowel disease can be recommended implemented in clinical practiceECCO '18 Vienna
2018